Antonella Zucchetto

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 162 publications

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

Journal: Blood advances

Published: October 22, 2025

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Journal: HemaSphere

Published: July 22, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study.

Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study.

Journal: Journal of clinical medicine

Published: June 12, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood

Published: May 14, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood

Published: May 14, 2025

Evaluation of Constitutive or Induced Activation State of the VLA-4 Integrin in Human and Murine Samples.

Evaluation of Constitutive or Induced Activation State of the VLA-4 Integrin in Human and Murine Samples.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 03, 2025

Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Journal: Leukemia

Published: February 13, 2025

Impact of opioid-free general anesthesia with locoregional blocks during breast cancer surgery on systemic inflammatory response: results from a randomized controlled trial.

Impact of opioid-free general anesthesia with locoregional blocks during breast cancer surgery on systemic inflammatory response: results from a randomized controlled trial.

Journal: Regional anesthesia and pain medicine

Published: February 05, 2025

CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Journal: Blood

Published: November 30, 2024

Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Journal: Leukemia

Published: August 13, 2024

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Journal: Blood advances

Published: July 19, 2024

Showing 1-12 of 162

Last Updated: 09/26/2026